94 related articles for article (PubMed ID: 8254961)
1. [A basic study on a highly sensitive automated method for hypercoagulable state in plasma, fluorogenic prothrombin time (FPT) method].
Ohki M; Tanaka S; Uchida K; Yamaguchi T; Kato H
Rinsho Byori; 1993 Oct; 41(10):1153-8. PubMed ID: 8254961
[TBL] [Abstract][Full Text] [Related]
2. Effect of N-acetylcysteine on the accuracy of the prothrombin time assay of plasma coagulation factor II+VII+X activity in subjects infused with the drug. Influence of time and temperature.
Thorsen S; Teisner A; Jensen SA; Philips M; Dalhoff K; Bendtsen F
Scand J Clin Lab Invest; 2009; 69(6):643-50. PubMed ID: 19530032
[TBL] [Abstract][Full Text] [Related]
3. Hypercoagulability in acute ischemic stroke: analysis of the extrinsic coagulation reactions in plasma by a highly sensitive automated method.
Takano K; Yamaguchi T; Okada Y; Uchida K; Kisiel W; Kato H
Thromb Res; 1990 Jun; 58(5):481-91. PubMed ID: 2368033
[TBL] [Abstract][Full Text] [Related]
4. Automated fluorogenic methods for the evaluation of the extrinsic coagulation reactions in human plasma.
Kato H; Uchida K
Thromb Res; 1988 Apr; 50(1):77-90. PubMed ID: 3400087
[TBL] [Abstract][Full Text] [Related]
5. [Optimized methods for measuring coagulation factors II, IV, VII and X in cats].
Mischke R; Deniz A; Nolte I
Dtsch Tierarztl Wochenschr; 1994 Nov; 101(11):430-3. PubMed ID: 7895622
[TBL] [Abstract][Full Text] [Related]
6. Comparison between British Comparative Thromboplastin (BCT) and a factor II-VII-X determination method (simplastin A) based on fresh plasma samples from dicoumarol-treated patients.
Korsan-Bengtsen K; Johsen M; Pehrsson NG
Thromb Haemost; 1977 Feb; 37(1):98-103. PubMed ID: 65801
[TBL] [Abstract][Full Text] [Related]
7. Factor VII clotting assay: influence of different thromboplastins and factor VII-deficient plasmas. CISMEL Study Group.
Poggio M; Tripodi A; Mariani G; Mannucci PM
Thromb Haemost; 1991 Feb; 65(2):160-4. PubMed ID: 2053102
[TBL] [Abstract][Full Text] [Related]
8. Preparation of canine factor VII deficient substrate plasma.
Gaston LW; Spivack AR
J Lab Clin Med; 1968 Oct; 72(4):548-55. PubMed ID: 5677303
[No Abstract] [Full Text] [Related]
9. Sensitivity of commercial prothrombin time reagents to detect coagulation factor deficiencies in equine plasma.
Mischke R; Junker J; Deegen E
Vet J; 2006 Jan; 171(1):114-9. PubMed ID: 16427588
[TBL] [Abstract][Full Text] [Related]
10. [Control of oral anticoagulation: comparison between Quick and colorimetric factor X determination in 107 patients].
Lämmle B; Eichlisberger R; Hänni L; Bounameaux H; Marbet GA; Duckert F
Schweiz Med Wochenschr; 1979 Aug; 109(30):1115-9. PubMed ID: 472699
[TBL] [Abstract][Full Text] [Related]
11. Plasma tissue factor plus activated peripheral mononuclear cells activate factors VII and X in cardiac surgical wounds.
Hattori T; Khan MM; Colman RW; Edmunds LH
J Am Coll Cardiol; 2005 Aug; 46(4):707-13. PubMed ID: 16098440
[TBL] [Abstract][Full Text] [Related]
12. Optimization of prothrombin time measurements in canine plasma.
Mischke R; Nolte I
Am J Vet Res; 1997 Mar; 58(3):236-41. PubMed ID: 9055967
[TBL] [Abstract][Full Text] [Related]
13. Stability of freeze-dried plasma prepared from patients on oral anticoagulants.
Brozović M; Howarth DJ; van Halem Visser LP; Loeliger EA
J Clin Pathol; 1973 Nov; 26(11):857-63. PubMed ID: 4797328
[TBL] [Abstract][Full Text] [Related]
14. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.
Erem C
Clin Endocrinol (Oxf); 2006 Mar; 64(3):323-9. PubMed ID: 16487444
[TBL] [Abstract][Full Text] [Related]
15. A new method for factor VII deficient substrate preparation and coagulation studies in malaria.
Rojanasthien S; Surakamollert V; Isarangkura P; Boonpucknavig S
Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 1():225-8. PubMed ID: 7886582
[TBL] [Abstract][Full Text] [Related]
16. Effects of coagulation factor deficiency on plasma coagulation kinetics determined via thrombelastography: critical roles of fibrinogen and factors II, VII, X and XII.
Nielsen VG; Cohen BM; Cohen E
Acta Anaesthesiol Scand; 2005 Feb; 49(2):222-31. PubMed ID: 15715625
[TBL] [Abstract][Full Text] [Related]
17. Thrombin generation in plasma of healthy adults and children: chromogenic versus fluorogenic thrombogram analysis.
Devreese K; Wijns W; Combes I; Van kerckhoven S; Hoylaerts MF
Thromb Haemost; 2007 Sep; 98(3):600-13. PubMed ID: 17849049
[TBL] [Abstract][Full Text] [Related]
18. Thrombin generation and coagulation factor activities: evaluation and comparison with the international normalized ratio.
Christensen TD; Jensen C; Larsen TB; Christiansen K; Sørensen B
Blood Coagul Fibrinolysis; 2009 Jul; 20(5):358-65. PubMed ID: 19417631
[TBL] [Abstract][Full Text] [Related]
19. Chromogenic assays for equine coagulation factors VII, VIII:C, IX, and X, and C1-esterase inhibitor.
Topper MJ; Prasse KW
Am J Vet Res; 1998 May; 59(5):538-41. PubMed ID: 9582952
[TBL] [Abstract][Full Text] [Related]
20. [Methodological studies on the immunologic determination of proconvertin (factor VII)].
Frenzel J; Maak B; Sachse U
Folia Haematol Int Mag Klin Morphol Blutforsch; 1975; 102(3):357-70. PubMed ID: 52582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
